Gene delivery using functional dendritic polymers

Expert Opinion on Drug Delivery

Volumn 6, Issue 1, 2009, Pages 27-38

  Paleos, Constantinos M ^a,b   Tziveleka, Leto Aikaterini ^a,b   Sideratou, Zili ^a   Tsiourvas, Dimitris ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b DendriGen AE   (Greece)

Author keywords

Dendrimers; Dendritic polymers; Dendrons; Gene delivery vectors; Hyperbranched polymers; Nanocarriers

Indexed keywords

ARGININE; ARGININE DERIVATIVE; ARGININE POLYAMIDOAMINE PEGPOLYAMIDOAMINE ARGININE; ASIALOGLYCOPROTEIN RECEPTOR; CATION; CHLOROQUINE; DENDRIGRAFT; DENDRIMER; DENDRITIC POLYMER; DENDRON; DNA; DRUG CARRIER; GUANIDINIUM DERIVATIVE; LIPOFECTAMINE; LIPOPOLYMER; LIPOSOME; MACROGOL; MANNOSE RECEPTOR; NANOCARRIER; NANOPARTICLE; PEPTIDE DERIVATIVE; POLYAMIDOAMINE; POLYAMIDOAMINE ARGININE; POLYAMIDOAMINE LYSINE; POLYETHER DERIVATIVE; POLYETHYLENEIMINE; POLYGLYCEROL; POLYMER; POLYPROPYLENEIMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CELL MEMBRANE; CELL STRAIN COS7; CELL STRAIN HEK293; CELL STRAIN HEPG2; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STRUCTURE; DRUG TRANSPORT; ENDOSOME; GENE VECTOR; GENETIC TRANSFECTION; HETEROZYGOTE DETECTION; HUMAN; INTERNALIZATION; LYSOSOME; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTON TRANSPORT; RECEPTOR BINDING; REVIEW; ANIMAL; CHEMISTRY; GENE THERAPY; GENE TRANSFER; METHODOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; DENDRIMERS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; POLYMERS; TRANSFECTION;

EID: 64749106130     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240802607345     Document Type: Review

References (70)

1. Zhu J, Tang A, Law LP, et al. Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers. Bioconjugate Chem 2005;16(1):139-146 (Pubitemid 40129687)
2. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997;389(6648):239-242 (Pubitemid 27406627)
3. Lotze MT, Kost TA. Viruses as gene delivery vectors: Application to gene function, target validation, and assay development. Cancer Gene Ther 2002;9(8):692-699 (Pubitemid 34847578)
4. Lundstrom K, Boulikas T. Viral and non-viral vectors in gene therapy: Technology development and clinical trials. Technol Cancer Res Treat 2003;2(5):471-485 (Pubitemid 37363005)
5. Ghosh SS, Gopinath P, Ramesh A. Adenoviral vectors - a promising tool for gene therapy. Appl Biochem Biotechnol 2006;133(1):9-29 (Pubitemid 43780431)
6. Nishikawa M, Huang L. Nonviral vectors in the new millennium: Delivery barriers in gene transfer. Hum Gene Ther 2001;12(8):861-870 (Pubitemid 32681851)
7. El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release 2004;94(1):1-14 (Pubitemid 37542373)
8. Krämer M, Stumbé JF, Grimm G, et al. Dendritic polyamines: Simple access to new materials with defined treelike structures for application in nonviral gene delivery. Chem BioChem 2004;5(8):1081-1087 (Pubitemid 39257028)
9. Yudovin-Farber I, Yanay C, Azzam T, et al. Quaternary ammonium polysaccharides for gene delivery. Bioconjugate Chem 2005;16(5):1196-1203 (Pubitemid 41368121)
10. Liu YM, Reineke TM. Poly(glycoamidoamine)s for gene delivery: stability of polyplexes and efficacy with cardiomyoblast cells. Bioconjugate Chem 2006;17(1):101-108 (Pubitemid 43157590)
11. Cavazzana-Calvo M, Thrasher A, Mavillo F. The future of gene therapy. Nature 2004;427(6977):779-781 (Pubitemid 38297723)
12. Vögtle F, Gestermann S, Hesse R, et al. Functional dendrimers. Prog Polym Sci 2000;25(7):987-1041 (Pubitemid 32030200)
13. Fréchet JMJ, Tomalia DA. Dendrimers and other dendritic polymers. Chichester. J Wiley & Sons; 2001 and references cited therein
14. Newkome GR, Moorefield CN, Vögtle F. Dendrimers and dendrons. Concepts, syntheses, perspectives. Weinheim: Wiley-VCH; 2001 and references cited therein
15. Svenson S, Tomalia DA. Dendrimers in biomedical applications - reflections on the field. Adv Drug Deliv Rev 2005;57(15):2106-2129 (Pubitemid 41759389)
16. Lee CC, MacKay JA, Fréchet JMJ, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol 2005;23(12):1517-1526 (Pubitemid 41752929)
17. Tomalia DA, Fréchet JMJ. Discovery of dendrimers and dendritic polymers: a brief historical perspective. J Polym Sci, Part A: Polym Chem 2002;40(16):2719-2728 (Pubitemid 34838729)
18. Veronese FM. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 2001;22(5):405-417 (Pubitemid 32007845)
19. Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002;54(4):459-476 (Pubitemid 34615543)
20. Vandermeulen GWM, Klok HA. Peptide/protein hybrid materials: Enhanced control of structure and improved performance through conjugation of biological and synthetic polymers. Macromol Biosci 2004;4(4):383-398 (Pubitemid 39257162)
21. Liu MJ, Kono K, Fréchet JMJ. Water-soluble dendrimer-poly(ethylene glycol) starlike conjugates as potential drug carriers. J Polym Sci, Part A: Polym Chem 1999;37(17):3492-3503
22. Liu MJ, Kono K, Fréchet JMJ. Water-soluble dendritic unimolecular micelles: Their potential as drug delivery agents. J Control Release 2000;65(1-2):121-131 (Pubitemid 30122921)
23. Gajbhiye V, Kumar PV, Tekade RK, et al. Pharmaceutical and biomedical potential of PEGylated dendrimers. Curr Pharm Des 2007;134:415-429 (Pubitemid 46477762)
24. Kumar PV, Agashe H, Dutta T, et al. PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. Curr Drug Deliv 2007;4(1):11-19 (Pubitemid 46066410)
25. Kaminskas LM, Boyd BJ, Karellas P, et al. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers. Mol Pharm 2008;5(3):449-463 (Pubitemid 351929829)
26. Lasic DD, Needham D. The 'Stealth' liposome: A prototypical biomaterial. Chem Rev 1995:958;2601-2628 and references cited therein
27. Pantos A, Tsiourvas D, Sideratou Z, et al. Interactions of complementary PEGylated liposomes and characterization of the resulting aggregates. Langmuir 2004;20(15):6165-6172
28. Silvander M, Hansson P, Edwards K. Liposomal surface potential and bilayer packing as affected by PEG-lipid inclusion. Langmuir 2000;16(8):3696-3702 (Pubitemid 30858694)
29. Kaasgaard T, Mouritsen OG, Jørgensen K. Screening effect of PEG on avidin binding to liposome surface receptors. Int J Pharm 2001;214(1-2):63-65 (Pubitemid 32244079)
30. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Delivery Rev 2004;56(11):1649-1659
31. Couvreur P, Gref R, Andrieux K, et al. Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases. Progr Solid State Chem 2006;34(2-4):231-235 (Pubitemid 43849902)
32. Gu FX, Karnik R, Wang AZ, et al. Targeted nanoparticles for cancer therapy. Nano Today 2007;2(3):14-21 (Pubitemid 46672835)
33. Beduneau A, Saulnier P, Benoit JP. Active targeting of brain tumors using nanocarriers. Biomaterials 2007;28(33):4947-4967 (Pubitemid 47362345)
34. Chari RVJ. Targeted cancer therapy: Conferring specificity to cytotoxic drugs. Acc Chem Res 2008;41(1):98-107
35. Petrak K. Essential properties of drug-targeting delivery systems. Drug Deliv Today 2005;10(23-24):1667-1673 (Pubitemid 41817615)
36. Mammen M, Choi S, Whitesides GM. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 1998;37(20):2754-2794 (Pubitemid 29008561)
37. Kitov PI, Bundle DR. On the nature of the multivalency effect: A thermodynamic model. J Am Chem Soc 2003;125(52):16271-16284 (Pubitemid 38020650)
38. Badjic JD, Nelson A, Cantrill SJ, et al. Multivalency and cooperativity in supramolecular chemistry. Acc Chem Res 2005;38(9):723-732 (Pubitemid 41442455)
39. Tung C-H, Weissleder R. Arginine containing peptides as delivery vectors. Adv Drug Deliv Rev 2003;55(2):281-294 (Pubitemid 36135919)
40. Futaki S. Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv Drug Deliv Rev 2005;57(4):547-558 (Pubitemid 40255560)
41. Rothbard JB, Jessop TC, Wender PA. Adaptive translocation: The role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv Drug Deliv Rev 2005;57(4):495-504 (Pubitemid 40255557)
42. Liu Z, Li M, Cui D, Fei J. Macro-branched cell-penetrating peptide design for gene delivery. J Control Release 2005;102(3):699-710 (Pubitemid 40170212)
43. Wender PA, Galliher WC, Goun EA, et al. The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliv Rev 2008;60(4-5):452-472
44. Theodossiou TA, Pantos A, Tsogas I, et al. Guanidinylated dendritic molecular transporters: prospective drug delivery systems and application in cell transfection. Chem Med Chem 2008;3(11):1635-1643
45. Sonawane ND, Szoka FC Jr, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 2003;278(45):44826-44831 (Pubitemid 37377241)
46. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci USA 1995;92(16):7297-7301
47. Kubasiak LA, Tomalia DA. Dendri-poly(amidoamines) and dendri-poly(propyleneimines). In: Amiji MM, editor, Polymeric Gene Delivery: Principles and applications. Boca Raton: CRC Press; 2004 . p. 133-157
48. Dufès C, Uchegbu IF, Schätzlein AG. Dendrimers in gene delivery. Adv Drug Delivery Rev 2005;57(15):2177-2202 (Pubitemid 41759392)
49. Guillot-Nieckowski M, Eisler S, Diederich F. Dendritic vectors for gene transfection. New J Chem 2007;31(7):1111-1127 (Pubitemid 47036618)
50. Boas U, Heegaard PMH. Dendrimers in drug research. Chem Soc Rev 2004;33(1):43-63 and references cited therein (Pubitemid 38376610)
51. Lee JH, Lim YB, Choi JS, et al. Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency. Bioconjugate Chem 2003;14(6):1214-1221 (Pubitemid 37449052)
52. Potocky TB, Silvius J, Menon AK, et al. HeLa cell entry by guanidinium-rich β-peptides: Importance of specific cation-cell surface interactions. ChemBioChem 2007;8(8):917-926 (Pubitemid 47194840)
53. Onda M, Yoshihara K, Koyano H, et al. Molecular recognition of nucleotides by the guanidinium unit at the surface of aqueous micelles and bilayers. A comparison of microscopic and macroscopic interfaces. J Am Chem Soc 1996;118(36):8524-8530 (Pubitemid 26318253)
54. Choi JS, Nam K, Park J, et al. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release 2004;99(3):445-456 (Pubitemid 39296913)
55. Kim T, Baek J, Yoon JK, et al. Synthesis and characterization of a novel arginine-grafted dendritic block copolymer for gene delivery and study of its cellular uptake pathway leading to transfection. Bioconjugate Chem 2007;18(2):309-317 (Pubitemid 46493500)
56. Tziveleka LA, Psarra AMG, Tsiourvas D, et al. Synthesis and characterization of guanidinylated poly(propylene imine) dendrimers as gene transfection agents. J Control Release 2007;117(1):137-146 (Pubitemid 46164865)
57. Kim T, Baek J, Bai CZ, Park J. Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. Biomaterials 2007;28(11):2061-2067 (Pubitemid 46176169)
58. Kono K, Akiyama H, Takahashi T, et al. Transfection Activity of Polyamidoamine Dendrimers Having Hydrophobic Amino Acid Residues in the Periphery. Bioconjugate Chem 2005;16(1):208-214 (Pubitemid 40129695)
59. Wood KC, Little SR, Langer R, et al. A family of hierarchically self-assembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery. Angew Chem Int Ed 2005;44(41):6704-8 • This paper sets forth the notion of multifunctionality for a dendritic gene delivery system.
60. Wood KC, Azarin SM, Arap W, et al. Tumor-targeted gene delivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide. Bioconjugate Chem 2008;19(2):403-405 (Pubitemid 351294909)
61. Kostiainen MA, Hardy JG, Smith DK. High affinity multivalent DNA binding by using low-molecular-weight dendrons. Angew Chem Int Ed 2005;44(17):2556-2559 (Pubitemid 40600329)
62. Hardy JG, Kostiainen MA, Smith DK, et al. Dendrons with spermine surface groups as potential building blocks for nonviral vectors in gene therapy. Bioconjugate Chem 2006;17(1):172-178 (Pubitemid 43157599)
63. Tang MX, Redemann CT, Szoka FC. In vitro. gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem 1996;7(6):703-714
64. Dennig J, Duncan E. Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers. Rev Mol Biotechnol 2002;90(3-4):339-347 (Pubitemid 34179580)
65. Kainthan RK, Gnanamani M, Ganguli M, et al. Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA. Biomaterials 2006;2731:5377-5390 (Pubitemid 44109897)
66. Tziveleka LA, Psarra AMG, Tsiourvas D, et al. Synthesis and evaluation of functional hyperbranched polyether polyols as prospected gene carriers. Int J Pharm 2008;356(1-2):314-324
67. Wang D, Narang AS, Kotb M, et al. Novel branched poly(ethylenimine)- cholesterol water soluble lipopolymers for gene delivery. Biomacromolecules 2002;3(6):1197-1207 (Pubitemid 35423019)
68. Sun HK, Ji HJ, Kyung CC, et al. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J Control Release 2005;104(1):223-232 (Pubitemid 40615249)
69. Kim WJ, Yockman JW, Lee M, et al. Soluble Flt.-1. gene delivery using PEI-g-PEG-RGD conjugate for antiangiogenesis. J Control Release 2005;106(1-2):224-234 (Pubitemid 41140097)
70. Kim WJ, Yockman JW, Jeong JH, et al. Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice. J Control Release 2006;114(3):381-388 (Pubitemid 44310812)